Frontlight ResearchEarly access
Taking peoplePhase 1
Long-term follow-up of people treated with genetically modified cell therapies
Monitors people from earlier cell therapy studies for late side effects of their treatment.
Key facts
- Who runs it
- USWM Ct LLC
- Where
- Amsterdam, NetherlandsSee the siteAlso in 3 other countries, 3 sites
- Registry title
- Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 12 people, planned
- Started
- 14 Sept 2020
- Expected to end
- 4 May 2038
- Type of study
- Interventional
- Record updated
- 16 November 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Participants who have received at least one dose of ADP adoptive cell therapy agent
- Participants who have completed ADP sponsored or supported interventional study or have withdrawn from it
- Participants who have completed treatment as part of managed access to an adoptive cell therapy
- Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies
- The investigator is responsible for review of medical history
- Capable of giving signed informed consent
Who cannot take part
- None
Where in Netherlands
Also in 3 other countries, 3 sites
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAmsterdam, NetherlandsNot yet recruiting
About the trial
What the trial wants to find out
To monitor participants for delayed AEs associated with administration of autologous cells that have been genetically modified.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Plain-language title
- Long-term follow-up of people treated with genetically modified cell therapiesGenerated from the registry record. The registry title is the official one.
- Record updated
- 16 November 2026